Literature DB >> 7753001

Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Pediatric Oncology Group.

P K Duffner1, M E Cohen, R A Sanford, M E Horowitz, J P Krischer, P C Burger, H S Friedman, L E Kun.   

Abstract

Eleven infants with pineoblastomas were treated with prolonged postoperative chemotherapy in an attempt to delay radiation and reduce neurotoxicity. These infants were part of the Pediatric Oncology Group infant brain tumor study but the outcome of infants with pineoblastomas was not previously reported. Ages ranged from 1 month to 35 months, with eight of 11 < or = 12 months at diagnosis. Four had + cytology and three had + myelograms at diagnosis. The majority had partial surgical resection (25-75% reduction in tumor) and 10 had shunts. Chemotherapy consisted of two 28-day cycles of cyclophosphamide plus vincristine, followed by one 28-day cycle of cisplatin plus etoposide. Craniospinal radiation was planned following completion of either 2 years of chemotherapy (children less than 24 months at diagnosis) or following one year (children 24-36 months at diagnosis). Neuroimaging results following two cycles of cyclophosphamide and vincristine were one partial response, five stable disease, and five progressive disease. There were no responders in the leptomeninges. All children ultimately failed chemotherapy (2 months-11 months). Nine failed in the primary site. Of those eight children in whom a metastatic workup was performed at time of progression, all had evidence of leptomeningeal disease. Six received radiation following failure on chemotherapy. All failed either in the primary site, leptomeninges or extraneurally (peritoneal cavity). All children died. Survival following diagnosis ranged from 4 months to 13 months. This chemotherapy regimen was neither effective in controlling tumor in the primary site nor in treating or preventing leptomeningeal spread.

Entities:  

Mesh:

Year:  1995        PMID: 7753001     DOI: 10.1002/mpo.2950250109

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  13 in total

1.  Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91.

Authors:  Bernward G Hinkes; Katja von Hoff; Frank Deinlein; Monika Warmuth-Metz; Niels Soerensen; Beate Timmermann; Uwe Mittler; Christian Urban; Udo Bode; Torsten Pietsch; Paul G Schlegel; Rolf D Kortmann; Joachim Kuehl; Stefan Rutkowski
Journal:  J Neurooncol       Date:  2006-08-29       Impact factor: 4.130

2.  Pineal parenchymal tumors. Management with interstitial iodine-125 radiosurgery.

Authors:  Mohammad Maarouf; Faycal El Majdoub; Christian Bührle; Jürgen Voges; Ralph Lehrke; Martin Kocher; Stefan Hunsche; Harald Treuer; Volker Sturm
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

3.  Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.

Authors:  Martin Mynarek; Barry Pizer; Christelle Dufour; Dannis van Vuurden; Miklos Garami; Maura Massimino; Jason Fangusaro; Tom Davidson; Maria Joao Gil-da-Costa; Jaroslav Sterba; Martin Benesch; Nicolas Gerber; B Ole Juhnke; Robert Kwiecien; Torsten Pietsch; Marcel Kool; Steve Clifford; David W Ellison; Felice Giangaspero; Pieter Wesseling; Floyd Gilles; Nicholas Gottardo; Jonathan L Finlay; Stefan Rutkowski; Katja von Hoff
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

Review 4.  The therapy of infantile malignant brain tumors: current status?

Authors:  Chantal Kalifa; Jacques Grill
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

Review 5.  Surgical strategies for treating patients with pineal region tumors.

Authors:  Jeffrey N Bruce; Alfred T Ogden
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

6.  Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.

Authors:  Carsten Friedrich; André O von Bueren; Katja von Hoff; Nicolas U Gerber; Holger Ottensmeier; Frank Deinlein; Martin Benesch; Robert Kwiecien; Torsten Pietsch; Monika Warmuth-Metz; Andreas Faldum; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski
Journal:  Neuro Oncol       Date:  2012-12-07       Impact factor: 12.300

Review 7.  Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience.

Authors:  P K Duffner; J P Krischer; P C Burger; M E Cohen; J W Backstrom; M E Horowitz; R A Sanford; H S Friedman; L E Kun
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

8.  Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN).

Authors:  Salvador Villà; Robert C Miller; Marco Krengli; Huda Abusaris; Brigitta G Baumert; Stephanie Servagi-Vernat; Sefik Igdem; Anna Lucas; Susanna Boluda; René O Mirimanoff
Journal:  Clin Transl Oncol       Date:  2012-08-23       Impact factor: 3.405

9.  Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy.

Authors:  Stephen W Gilheeney; Ali Saad; Susan Chi; Christopher Turner; Nicole J Ullrich; Liliana Goumnerova; R Michael Scott; Karen Marcus; Leslie Lehman; Umberto De Girolami; Mark W Kieran
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

10.  Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors.

Authors:  Cynthia J Campen; Joanna Dearlove; Sonia Partap; Patricia Murphy; Iris C Gibbs; Gary V Dahl; Paul Graham Fisher
Journal:  J Neurooncol       Date:  2012-09-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.